European Healthtech startup funding raised during July 2022.
In July 2022, 51 European Healthtech companies raised a combined €929M across 53 funding rounds, down 24.8% versus July 2021. Germany led by capital raised, and Bpifrance was the most active investor. Data as of 9 Jul 2026.
5 exits · €1.2B disclosed.
| TeneoTwo | Acquisition | Jul 2022 | €1.2B |
| €99M |
| Replay | Seed | Jul 2022 | €54M |
| Vectivbio | Other | Jul 2022 | €52M |
| Agomab Therapeutics | Series B | Jul 2022 | €41M |
| Unobravo | Series A | Jul 2022 | €17M |
| Nuclera | Series B | Jul 2022 | €15M |
| Pangaea | Other | Jul 2022 | €12M |
| Biosyntia | Other | Jul 2022 | €12M |
| Core Biogenesis | Series A | Jul 2022 | €10M |
| Morrow Eyewear | Growth/Late | Jul 2022 | €10M |
| PreciPoint | Series A | Jul 2022 | €10M |
| Navinci Diagnostics | Series A | Jul 2022 | €8.5M |